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SpainAbstractSeveral isolates of four different carbapenemase-producing
Enterobacteriaceae species were recovered from a patient
hospitalized for 4 months in a teaching hospital in Madrid. These
species comprised seven Klebsiella pneumoniae belonging to ST15,
four Escherichia coli belonging to ST2531, two Serratia marcescens
and one Citrobacter freundii. This patient was the index case of a
small outbreak of four patients infected and/or colonized by
carbapenemase-producing K. pneumoniae. Molecular results
identiﬁed the blaOXA-48 gene in all Enterobacteriaceae isolates
from the index case and in all isolates from the other three
patients, suggesting intra- and interpatient dissemination. Our
results highlight the great ability of OXA-48 carbapenemase to
spread among different enterobacterial species by both clonal and
nonclonal dissemination.
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p://dx.doi.org/10.1016/j.cmi.2014.07.008The increase of infections due to carbapenemase-producing
Enterobacteriaceae (CPE) constitutes a major and serious pub-
lic health concern because carbapenems are the last therapeutic
option for infections caused bymultidrug-resistant bacteria [1,2].
OXA-48-type enzymes hydrolyse carbapenems but do not
have activity against extended-spectrum cephalosporins and
aztreonam [3]. During the last 3 years, the OXA-48-producing
Klebsiella pneumoniae isolates have increased in Spain due to
both clonal and nonclonal dissemination, mainly in hospital
environments [4]. Here we report the characterization of
different OXA-48-producing enterobacterial species isolated
from a single patient in a period of time not exceeding 4
months. This horizontal interspecies dissemination was con-
current with a clonal spread of the OXA-48-producing
K. pneumoniae among four different patients.
Antibiotic susceptibility was carried out by the commercial
microdilutionmethodWIDER (Francisco SoriaMelguizo,Madrid,
Spain) and disk-diffusion/Etest methods (AB bioMérieux, Solna,
Sweden) according to the EuropeanCommittee onAntimicrobial
Susceptibility Testing guidelines (http://www.eucast.org). Carba-
penemase production was detected using colorimetric CarbaNP
[5], modiﬁed Hodge test [6] and carbapenemase inhibition tests
(Rosco Diagnostica, Taastrup, Denmark). In addition, temocillin
susceptibility was also determined by Etest [7].
The presence of genes encoding carbapenemases, extended-
spectrum β-lactamases (ESBLs) and plasmid-mediated AmpC
was conﬁrmed by polymerase chain reaction (PCR) and DNA
sequencing [8].
A 59-year-old white woman was admitted to the intensive
care unit (ICU) of a teaching hospital in Madrid (Spain) for
sepsis resulting from surgical treatment of an abdominal ab-
scess. On the second admission day in the ICU, a positive rectal
swab culture was obtained as part of a standard procedure of
surveillance; the sample was nonsusceptible to carbapenem
OXA-48-producing K. pneumoniae isolate and was only sus-
ceptible to amikacin, fosfomycin, colistin and tigecycline.
The patient was subjected to a digestive decolonization
treatment (SDD) (oral vancomycin and colistin and rectal/
topical tobramycin, vancomycin, colistin and nistatin) for 2
weeks as part of a selective decontamination protocol followed
in the ICU of this hospital to control the gut overgrowth and to
diminish the risk of both primary and secondary endogenous
infections in critical ill patients [9]. Subsequent surveillance
samples (twice a week), including throat and gut samples and a
broth-enrichment stage to detect very low concentrations of
microorganisms [9], were negative for carbapemase-producing
K. pneumoniae. Sixteen days later, the patient was discharged
from the ICU to the general internal medicine department for
follow-up.ious Diseases. Published by Elsevier Ltd. All rights reserved
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urinary tract infections originated by K. pneumoniae and Serratia
marcescens, both OXA-48 producers. The patient received
intravenous imipenem–cilastatin for 3 weeks, but then the
antibiotic treatment was replaced by oral fosfomycin–
trometamol for 3 days because of the persistence of
S. marcescens with increased resistance to carbapenems
(Table 1); this replacement led to a signiﬁcant clinical
improvement. During the following month, different rectal
swabs collected for surveillance control twice a week were
positive for K. pneumoniae, Escherichia coli with and without
resistance to third-generation cephalosporins and Citrobacter
freundii with decreased susceptibility to carbapenems; all of
them were conﬁrmed as OXA-48 producers. In addition,
samples from the surgical wound were also positive for OXA-
48-producing K. pneumoniae, E. coli and S. marcescens. All the
Enterobacteriaceae isolates identiﬁed are summarized in
Table 1.
Pulsed-ﬁeld gel electrophoresis (PFGE) results, after total
chromosomal DNA digestion with XbaI [8], revealed that all
seven K. pneumoniae and four E. coli isolates from the same
patient were undistinguishable. By multilocus sequence typing,
these strains were found to belong to ST15 and ST2531 ac-
cording to the Institut Pasteur scheme for K. pneumoniae
(http://www.pasteur.fr/recherche/genopole/PF8/mlst/
Kpneumoniae.html) and the University of Warwick scheme for
E. coli (http://mlst.warwick.ac.uk/mlst/), respectively.
K. pneumoniae ST15 isolates have been previously described
associated with CTX-M-15-producing epidemic clones [10,11]
and with the production of OXA-48 and VIM-1 types carba-
penemases [1]. E. coli ST2531 is an infrequent single locus
variant of ST399 (allele 7 instead 20 of the gene recA) and of
ST635 (allele 4 instead 107 of the gene fumC) (http://mlst.
warwick.ac.uk/mlst/; data last accessed in June 2014).TABLE 1. Molecular characterization of OXA-48-producing Entero
Admission
day Isolate source Specie
Antibiotic MIC (mg/L) by Etest
CarbapenemERT MER IMP
2* Rectal swab Kpn >32 3 3 OXA-48
23 Urine Kpn >32 4 8 OXA-48
34 Wound (buttock) Kpn >32 4 3 OXA-48
Sma 4 2 8 OXA-48
51 Urine Sma >32 4 >32 OXA-48
69 Rectal swab Eco 24 2 8 OXA-48
Kpn >32 3 12 OXA-48
77 Wound (left hip) Eco 24 2 6 OXA-48
Kpn >32 2 8 OXA-48
83 Rectal swab Eco 24 2 8 OXA-48
91 Rectal swab Cfr >32 4 4 OXA-48
Eco 24 2 8 OXA-48
98 Rectal swab Kpn >32 4 4 OXA-48
105 Surgical wound Kpn >32 4 4 OXA-48
MIC, minimum inhibitory concentration; PFGE, pulsed-ﬁeld gel electrophoresis; MLST, mult
meropenem, MER; IMP, imipenem; ND, not determined. NA, not applicable; Kpn, Klebsiella
*Start of selective digestive decolonization treatment.
Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and InThe blaOXA-48 gene was identiﬁed in all studied Enter-
obacteriaceae isolates. Nine of them, all seven K. pneumoniae as
well as two E. coli isolates, had also the blaCTX-M-15 gene. Plasmid-
mediated AmpC β-lactamases were not detected. S. marcescens
and C. freundii isolates were characterized as overproducers of
chromosomic AmpC enzyme on the basis of their resistance to
amoxicillin–clavulanic acid and cefoxitin, and inhibition with
phenyl boronic acid and cloxacillin. All OXA-48-producing
K. pneumoniae, E. coli, S. marcescens and C. freundii isolates were
resistant to temocillin (>128mg/L) and positive by theHodge test
and the CarbaNP method; in addition, carbapenemase activity
was not inhibited by EDTA, phenyl boronic acid or cloxacillin.
Conjugation was attempted with six representative isolates
(two ST15 K. pneumoniae, two ST2531 E. coli, one S. marcescens
and one C. freundii) according to PFGE proﬁles; kanamycin–
azide-resistant E. coli Hb101 was used as a recipient. Putative
transconjugants were selected on Mueller-Hinton agar plates
containing kanamycin (100 mg/L), azide (160 mg/L) and erta-
penem (0.25 mg/L). Plasmids detection was performed by PFGE
with S1 nuclease digestion of whole genomic DNA [12]. Plas-
mids were classiﬁed according to their incompatibility group
by PCR-based typing targeting genes identiﬁed from other
blaOXA-48-bearing plasmids as previously described [13], and by
PCR-based replicon-typing schemes according to Carattoli et al.
[14] and Galimand et al. [15]. Results showed that all isolates
had an IncL/M plasmid of ~65 kb carrying the blaOXA-48 gene.
blaOXA-48 gene, but not blaCTX-M-15, was also detected in
transconjugants obtained from all six representative isolates
tested. Remarkably, PCR with primers by Carattoli et al.
repeatedly ampliﬁed a ~450 pb amplicon; the sequence of this
DNA fragment showed 100% homology with several GenBank
sequences (e.g. KC354801.01, JN626286.1, KC757416.2,
KC757417.2) corresponding with rep genes of IncL/M plasmids
carrying the blaOXA-48 gene. Previously it had been describedbacteriaceae isolates in index case
ase
Other
β-lactamases PFGE MLST Plasmids Transposon
CTX-M-15 P1 ST15 ~65 kb/IncL/M; ~90 kb; ~195 kb Tn1999.2
CTX-M-15 P1 ST15 ~65 kb/IncL/M; ~90 kb; ~195 kb Tn1999.2
CTX-M-15 P1 ST15 ND ND
AmpCc P3 NA ~65 kb/IncL/M Tn1999.2
AmpCc P3 NA ND ND
— P2 ST2531 ~65 kb/IncL/M Tn1999.2
CTX-M-15 P1 ST15 ND ND
— P2 ST2531 ND ND
CTX-M-15 P1 ST15 ND ND
CTX-M-15 P2 ST2531 ~65 kb/IncL/M; ~115 kb Tn1999.2
AmpCc NA NA ~65 kb/IncL/M; ~100 kb; ~150 kb Tn1999.2
CTX-M-15 P2 ST2531 ND ND
CTX-M-15 P1 ST15 ND ND
CTX-M-15 P1 ST15 ND ND
ilocus sequence typing; AmpCc, chromosomic AmpC β-lactamase; ERT, erythromycin;
pneumoniae; Eco, Escherichia coli; Sma, Serratia marcescens; Cfr, Citrobacter freundii.
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IncL/M replicon of the plasmids carrying blaOXA-48 [16]. This
plasmid of ~65 kb was the single one detected in S. marcescens
and one E. coli isolates. This E. coli did not produce ESBL en-
zymes, and carbapenemase production was not suspected with
the antibiotic susceptibility proﬁle obtained by usual identiﬁ-
cation/susceptibility method (minimal inhibitory concentrations
of <1 mg/L, <2 mg/L and <2 mg/L to imipenem, meropenem
and ertapenem, respectively). However, K. pneumoniae isolates
had two additional plasmids of ~90 kb and ~195 kb, and the
E. coli producing both OXA-48 and CTX-M-15 had an addi-
tional plasmid of ~115 kb. C. freundii had also two additional
plasmids of ~100 kb y ~150 kb (Table 1). The high frequency of
blaCTX-M-15 and blaOXA-48 coexpression is of great concern
because of the previous wide dissemination of CTX-M-15 [17].
In all six representative isolates, blaOXA-48 was carried by the
composite transposon Tn1999.2 [18] with the IS1R inserted
upstream of blaOXA-48 (Table 1).
The main objective of SDD strategy is to control the gut
overgrowth, but usually not eradication [9,19], of CPE carriage
for prevent endogenous infections by potential pathogens in
critical ill patients. SDD is a well-documented and evidence-
based strategy in these patients from ICUs [9], but limited
clinical data are available for patients infected or colonized by
CPE [19,20]. In this case, SDD was, in our opinion, effective
during the patient’s stay in the ICU because CPE isolates were
not detected for at least 38 days. However, this strategy had no
long-term effect and the probably not eradicated OXA-48-
producing K. pneumoniae had overgrown to becomeSeptember 
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Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectdetectable again. In addition, a possible role of the previous
SDD strategy as a helper to the wide interspecies carbapene-
mase dissemination should be considered in future studies.
Despite the prompt application of speciﬁc interventions as
contact isolation of the patient, rectal swabs collection to
detect carriers as surveillance control and improving the
application of infection control practices, this patient was the
index case of a small outbreak of four patients. We do not
know for sure when the outbreak started, but the contact
probably took place when the OXA-48-producing
K. pneumoniae was again detectable in the internal medicine
department. At this point, it is not possible to assure that the
index patient did contact other patients in a wrong-contact
isolation context; this was probably the starting point for the
outbreak (Fig. 1). SDD was not applied to these patients.
Previously, no OXA-48-producing isolates had been isolated
in this hospital. All four affected patients were colonized by, and
two of them were also infected by, OXA-48- and CTX-M-15-
producing K. pneumoniae. By PFGE, all of them had the same
K. pneumoniae strain of the index case (Table 2). In two of them,
OXA-48-producing E. coli isolates with different PFGE proﬁles,
different from those from the index case, were also isolated
from a rectal swab sample, again suggesting an interspecies
spread. They did not produce ESBL enzymes.
In conclusion, this report highlights the ability of OXA-48
carbapenemase to spread among different enterobacterial
species by both clonal and nonclonal dissemination. These
ﬁndings are of great epidemiologic and clinical interest because
early identiﬁcation and surveillance strategies are essential to4th case 
Kpn/rectal 
Eco/rectal 
Kpn/rectal 
Eco/rectal
Contact with 
IC 
FIG. 1. Development of outbreak over time
(4 months) and patients involved. Continuous
blue arrows show the OXA-48-producing
enterobacteria isolated in the index case.
Discontinuous blue arrows show the OXA-
48-producing enterobacteria isolated in the
rest of patients. Epidemic OXA-48-producing
K. pneumoniae (Kpn) is marked in bold.
Continuous black arrows indicate the
moment in which the other infected/colo-
nized patients were in contact with the index
case. Grey square shows the strains isolated
form the same sample. Kpn, Klebsiella pneu-
moniae; Smar, Serratia marcescens; Eco,
Escherichia coli; Cfr, Citrobacter freundii; IC,
index case.
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 148.e1–148.e4
TABLE 2. Molecular characterization of OXA-48-producing Enterobacteriaceae isolates in other outbreak subjects
Patient Isolate source Species Infection status PGFE MLST
2 Rectal and blood Kpn Colonized/infected P1 ST15
3 Rectal Kpn Colonized P1 ST15
Rectal Eco Colonized P4 ND
4 Rectal Kpn Colonized P1 ST15
Rectal Eco Colonized P5 ND
PFGE, pulsed-ﬁeld gel electrophoresis; MLST, multilocus sequence typing; Kpn, Klebsiella pneumoniae; Eco, Escherichia coli.
CMI Arana et al. Dissemination of OXA-48 carbapenemase 148.e4prevent nosocomial outbreaks. In addition, decontamination
strategies could be a suitable therapy for selected patients
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